DeepIntent Unveils Cora, an Agentic AI Platform for Healthcare Marketing
Event summary
- DeepIntent launched Cora, an agentic AI platform designed to streamline healthcare marketing workflows.
- Cora integrates market intelligence, strategy, and omnichannel campaign activation in a single interface.
- Beta testing showed a 50% reduction in marketing planning time cycles for 95% of customers.
- The platform leverages DeepIntent Helix, an expanded healthcare marketing cloud with new data types.
The big picture
DeepIntent's Cora addresses a critical gap in healthcare marketing, where over 60% of drug treatments fail to meet commercial goals. The platform's agentic AI capabilities aim to streamline collaboration and activation across omnichannel campaigns, aligning with the industry's shift toward more precise patient targeting. By integrating data, intelligence, and execution in a single interface, Cora could redefine how pharma companies strategize and execute marketing campaigns.
What we're watching
- Adoption Pace
- How quickly pharma companies and agencies will integrate Cora into their existing workflows.
- Competitive Response
- Whether competitors will accelerate their own AI-driven marketing solutions in response.
- Market Impact
- The extent to which Cora can improve the commercial success rates of specialized drug treatments.
Related topics